The annual per capita pharmaceutical sales are less than US$32. Most of this spent is out of the pocket. By providing a big portfolio of 140 products with a relative low price, GSK is winning the ...

British pharmaceutical giant GSK has not met required ethical and regulatory standards in the marketing and prescription ...

A doctor and a patient discussing a therapy plan that includes pharmaceutical products. A caller asked if Cramer deviated from his previous bullishness on GSK plc (NYSE:GSK), in light of the ...

Trump administration probing extent to which pharmaceutical imports may threaten national security, a likely prelude to ...

If the tariff-loving Trump goes ahead with his plans, it will hit AstraZeneca - the most valuable company on the UK stock ...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorised GSK’s Blenrep for treating multiple ...

The FDA will remove industry representatives from advisory committees and replace them with patients and caregivers ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities ...

GSK has secured the first regulatory approval for Blenrep since the antibody-drug conjugate’s global market withdrawal in 2022. | GSK has secured the first regulatory approval for Blenrep since the ...